German Pharmaceuticals
- All
- News
-
Pfizer Vaccine Can Neutralise UK, South Africa Virus Variants: Study
The COVID-19 vaccine co-developed by the American pharmaceutical giant Pfizer and the German biotechnology company BioNTech can neutralise variants of the novel coronavirus that were first reported in the UK and South Africa, a new study suggests.
-
China's Fosun Pharma To Import 100 Million BioNTech Vaccine Doses
A Chinese pharmaceutical company said Wednesday it had agreed to buy at least 100 million doses of the coronavirus vaccine from German company BioNTech, subject to Beijing approving its use.
-
Pfizer, Centre Open To Talks To Make Covid Vaccine Available In India
The COVID-19 vaccine candidate developed by US pharmaceutical giant Pfizer and German biotech firm BioNTech has brought hope since the announcement yesterday about its 90 per cent efficacy. But it looks unlikely that India would have it anytime soon, though both Pfizer and the Health Ministry have indicated they are open for talks.
-
India's Serum Institute, Partners Join Race To Develop COVID-19 Treatment
The Serum Institute of India on Thursday said it has entered into an agreement with German pharmaceutical giant Merck and New York-based non-profit health research organisation IAVI to develop a treatment for people infected by the coronavirus.
-
Wockhardt Surges 8% As German Regulator Clears Ankaleshwar Plant
Shares of pharmaceutical company Wockhardt surged as much as 8 per cent to hit intraday high of Rs 728.
-
Bayer Ups Sales Targets For Top-Selling Drugs After Monsanto Deal
German drugmaker Bayer said its two best-selling drugs had a higher annual peak sales potential than previously targeted, after the agreed $66 billion takeover of Monsanto stirred criticism it might neglect its pharmaceuticals business.
-
Bayer Sweetens Monsanto Bid As Talks Enter Final Stretch
German pharmaceutical and crops manufacturer Bayer AG said on Monday that its negotiations with Monsanto Co had advanced, and that it was now willing to offer more than $65 billion to acquire the world's largest seeds company.
-
Monsanto, Object Of Bayer Desire Despite Genetically-Modified Crop Fears
German pharmaceutical giant Bayer sees in agro-industry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
-
Bayer Sued In Germany Over Contraceptive Pill After Health Scares
"If I'd known, I'd never have taken this pill," says Felicitas Rohrer, who is suing German pharmaceuticals giant Bayer, claiming its oral contraceptive Yasminelle caused her to suffer a pulmonary embolism.
-
Wall Street Falls After Weak German Data; Earnings Eyed
US stocks were down in morning trading on Tuesday, pressured by a second straight day of weak data out of Germany, the euro zone's largest economy, but indices bounced off of session lows.
-
Germany's Bayer vows to fight for anti-cancer drug patent in India
German pharmaceuticals giant Bayer, maker of Aspirin, vowed Monday to fight a ruling by the patent authorities in India allowing a local company to produce and sell a generic copy of its anti-cancer drug Nexavar.
-
Bayer files suit against Lupin over generic birth control pill
German drugmaker Bayer has filed a suit in the United States against Indian generic drug maker Lupin, to prevent it from selling a version of Bayer's birth-control pill Natazia there.
-
Pfizer Vaccine Can Neutralise UK, South Africa Virus Variants: Study
The COVID-19 vaccine co-developed by the American pharmaceutical giant Pfizer and the German biotechnology company BioNTech can neutralise variants of the novel coronavirus that were first reported in the UK and South Africa, a new study suggests.
-
China's Fosun Pharma To Import 100 Million BioNTech Vaccine Doses
A Chinese pharmaceutical company said Wednesday it had agreed to buy at least 100 million doses of the coronavirus vaccine from German company BioNTech, subject to Beijing approving its use.
-
Pfizer, Centre Open To Talks To Make Covid Vaccine Available In India
The COVID-19 vaccine candidate developed by US pharmaceutical giant Pfizer and German biotech firm BioNTech has brought hope since the announcement yesterday about its 90 per cent efficacy. But it looks unlikely that India would have it anytime soon, though both Pfizer and the Health Ministry have indicated they are open for talks.
-
India's Serum Institute, Partners Join Race To Develop COVID-19 Treatment
The Serum Institute of India on Thursday said it has entered into an agreement with German pharmaceutical giant Merck and New York-based non-profit health research organisation IAVI to develop a treatment for people infected by the coronavirus.
-
Wockhardt Surges 8% As German Regulator Clears Ankaleshwar Plant
Shares of pharmaceutical company Wockhardt surged as much as 8 per cent to hit intraday high of Rs 728.
-
Bayer Ups Sales Targets For Top-Selling Drugs After Monsanto Deal
German drugmaker Bayer said its two best-selling drugs had a higher annual peak sales potential than previously targeted, after the agreed $66 billion takeover of Monsanto stirred criticism it might neglect its pharmaceuticals business.
-
Bayer Sweetens Monsanto Bid As Talks Enter Final Stretch
German pharmaceutical and crops manufacturer Bayer AG said on Monday that its negotiations with Monsanto Co had advanced, and that it was now willing to offer more than $65 billion to acquire the world's largest seeds company.
-
Monsanto, Object Of Bayer Desire Despite Genetically-Modified Crop Fears
German pharmaceutical giant Bayer sees in agro-industry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
-
Bayer Sued In Germany Over Contraceptive Pill After Health Scares
"If I'd known, I'd never have taken this pill," says Felicitas Rohrer, who is suing German pharmaceuticals giant Bayer, claiming its oral contraceptive Yasminelle caused her to suffer a pulmonary embolism.
-
Wall Street Falls After Weak German Data; Earnings Eyed
US stocks were down in morning trading on Tuesday, pressured by a second straight day of weak data out of Germany, the euro zone's largest economy, but indices bounced off of session lows.
-
Germany's Bayer vows to fight for anti-cancer drug patent in India
German pharmaceuticals giant Bayer, maker of Aspirin, vowed Monday to fight a ruling by the patent authorities in India allowing a local company to produce and sell a generic copy of its anti-cancer drug Nexavar.
-
Bayer files suit against Lupin over generic birth control pill
German drugmaker Bayer has filed a suit in the United States against Indian generic drug maker Lupin, to prevent it from selling a version of Bayer's birth-control pill Natazia there.
